Several small clinical studies however have

Several small clinical studies, however, have successfully harnessed MDMA’s potent properties to treat severe cases of post-traumatic stress disorder, and the Food and Drug Administration in November granted permission for a large-scale Phase 3 clinical trial.
-
The FDA granted permission for a large-scale Phase 3 clinical trial to study the efficacy of treating PTSD with MDMA.